Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/534| Title: | Golimumab, a Human Anti–Tumor Necrosis Factor Monoclonal Antibody, Injected Subcutaneously Every 4 Weeks in Patients With Active Rheumatoid Arthritis Who Had Never Taken Methotrexate: 1‐Year and 2‐Year Clinical, Radiologic, and Physical Function Findings of a Phase III, Multicenter, Randomized, Double‐Blind, Placebo‐Controlled Study | Authors: | Park, Won Amante, Eric Fleischmann, Roy M Emery, Paul Strusberg, Ingrid Durez, Patrick Pons‐Estel, Bernardo Churchill, Melvin Nash, Peter Doyle, Mittie K |
Issue Date: | 2013 | Source: | 65, (11), 2013, p. 1732-1742 | Pages: | 1732-1742 | Journal: | Arthritis Care & Research | Type: | Article |
| Appears in Sites: | Sunshine Coast HHS Publications |
Show full item record
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.